474 related articles for article (PubMed ID: 15123578)
41. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
Misaka T; Suzuki S; Miyata M; Kobayashi A; Shishido T; Ishigami A; Saitoh S; Hirose M; Kubota I; Takeishi Y
Cardiovasc Res; 2013 Aug; 99(3):461-70. PubMed ID: 23723062
[TBL] [Abstract][Full Text] [Related]
42. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
43. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
[TBL] [Abstract][Full Text] [Related]
44. Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.
Qin W; Rudolph AE; Bond BR; Rocha R; Blomme EA; Goellner JJ; Funder JW; McMahon EG
Circ Res; 2003 Jul; 93(1):69-76. PubMed ID: 12791709
[TBL] [Abstract][Full Text] [Related]
45. Evidence for the importance of adiponectin in the cardioprotective effects of pioglitazone.
Li P; Shibata R; Unno K; Shimano M; Furukawa M; Ohashi T; Cheng X; Nagata K; Ouchi N; Murohara T
Hypertension; 2010 Jan; 55(1):69-75. PubMed ID: 19933924
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
[TBL] [Abstract][Full Text] [Related]
47. Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis.
Ikeda Y; Aihara K; Sato T; Akaike M; Yoshizumi M; Suzaki Y; Izawa Y; Fujimura M; Hashizume S; Kato M; Yagi S; Tamaki T; Kawano H; Matsumoto T; Azuma H; Kato S; Matsumoto T
J Biol Chem; 2005 Aug; 280(33):29661-6. PubMed ID: 15961403
[TBL] [Abstract][Full Text] [Related]
48. CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.
Xu J; Lin SC; Chen J; Miao Y; Taffet GE; Entman ML; Wang Y
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H538-47. PubMed ID: 21572015
[TBL] [Abstract][Full Text] [Related]
49. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
[TBL] [Abstract][Full Text] [Related]
50. Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion.
Sam F; Xie Z; Ooi H; Kerstetter DL; Colucci WS; Singh M; Singh K
Am J Hypertens; 2004 Feb; 17(2):188-93. PubMed ID: 14751663
[TBL] [Abstract][Full Text] [Related]
51. Deficiency of T-type Ca
Thuesen AD; Finsen SH; Rasmussen LL; Andersen DC; Jensen BL; Hansen PBL
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F254-F263. PubMed ID: 31042060
[TBL] [Abstract][Full Text] [Related]
52. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T
Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599
[TBL] [Abstract][Full Text] [Related]
53. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
Zhang C; Li Y; Wang C; Wu Y; Du J
Am J Hypertens; 2014 Jun; 27(6):857-64. PubMed ID: 24419904
[TBL] [Abstract][Full Text] [Related]
54. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
Tsushima K; Osawa T; Yanai H; Nakajima A; Takaoka A; Manabe I; Ohba Y; Imai Y; Taniguchi T; Nagai R
FASEB J; 2011 May; 25(5):1531-43. PubMed ID: 21266535
[TBL] [Abstract][Full Text] [Related]
55. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
56. Complement component C3 and the TLR co-receptor CD14 are not involved in angiotensin II induced cardiac remodelling.
Shahini N; Schjalm C; Nilsson PH; Holt MF; Øgaard JDS; Lien E; Ahmed MS; Attramadal H; Aukrust P; Yndestad A; Mollnes TE; Louwe MC
Biochem Biophys Res Commun; 2020 Mar; 523(4):867-873. PubMed ID: 31955888
[TBL] [Abstract][Full Text] [Related]
57. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
[TBL] [Abstract][Full Text] [Related]
58. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
59. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo.
Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837
[TBL] [Abstract][Full Text] [Related]
60. Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice.
Lund AK; Goens MB; Nuñez BA; Walker MK
Toxicol Appl Pharmacol; 2006 Apr; 212(2):127-35. PubMed ID: 16099489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
